HOXD9 and hepatocellular carcinoma: Consistent with previous studies, HOXD9 was significantly associated with prognosis of NAFLD patients in this analysis, indicating that HOXD9 may be an effective clinical therapeutic target for NAFLD of HCC with cirrhosis.